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ABSTRACT 
Background:  Abnormal uterine bleeding (AUB) is a major health problem and it is a substantial 
cause of ill health in women. Medical treatment has a high failure rate and adverse effects. There 
are few published data on hysteroscopic endometrial resection (HER) in the management of patients 
with AUB. 
Objective: To investigate the efficacy and outcomes of hysteroscopic endometrial resection (HER) 
in patients with AUB.  
Materials and Methods: A descriptive hospital - based study was carried out at the departments of 
Obstetrics and Gynecology, Misurata and Sirt, Libya, during the period from January 2009 to 
December 2013. Women with AUB were recruited in the study. All women had a detailed medical 
and obstetrical history, physical examination and the hysteroscopic endometrial ablation and were 
followed-up for success or failure of the procedure which was assessed via symptoms (bleeding).   
Results:   A total of 120 women with mean (SD) of age and parity of 42.3 (6.8) years and 3.8 (2.4), 
respectively were recruited in the study initially.   Thirty (25%) of these women were lost of follow-
up   Therefore, only 70 women (50 with DUB, and 20 women with fibroids) were available for the 
final analysis.  All women underwent hysteroscopic endometrial resection and 28 of them had 
hysteroscopic myomectomy. The success rate was 92.8% (65/70) after 2 years follow up. All the 
five women with failure of the procedure were younger (<40 years); had bleeding with 
dysmenorrhea, bigger uterine size, thicker endometrium (> 7 mm) and they had fibroids.   
Conclusions: Endometrial resection is an effective procedure in the majority of women with AUB, 
especially in those over age of 40 and without an increase in uterine size and has no fibroids. 
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bnormal uterine bleeding (AUB) is a 
substantial cause of ill health in 
women worldwide where it accounts 
for up to 20% of visits to the gynecologist1. It 
has been shown that 79% of women with UB 
might not have identifiable source of such 
bleeding (polyps, myomas, hyperplasia, or 
carcinoma), and subsequently leave the 
clinician with a "diagnosis of exclusion" of  
dysfunctional or anovulatory uterine bleeding 
(DUB)2.  Therefore reasons for such 
dysfunction  and  the  actual  mechanisms   of  
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bleeding are still unclear.  Once a proper 
diagnosis is established, there is again no 
consensus on the best treatment, including 
surgical approaches versus non-surgical 
approaches with hormonal and nonhormonal 
drug therapy. 
Drug therapy is usually the first line of 
treatment, yet its results are variable and 
transient, reducing the blood loss by at most 
50%.  Antifibrinolytic agents, non-steroidal 
anti-inflammatory drugs have been used to 
reduce the excessive bleeding 3-5.  Danazol 
and Gonadotropin releasing hormone (GnRH) 
analogue treatment although effective, they 
usually not tolerated for long periods of time, 
due to its side effects 5,6.  Cyclical 
progestogens can be used for short-term 
treatment of menorrhagia7 whereas 
Levonorgestrel-releasing intrauterine system 
A 
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(LNG IUS) found to be effective and less 
invasive especially in younger patients with a 
desire to preserve fertility 8,9. 
Surgery for AUB is usually preferred after 
unsuccessful medical treatment or when this 
therapy is contraindicated.  Uterine curettage, 
long used as diagnostic or therapeutic 
method, proved inefficient for both. 
Hysterectomy has been traditionally 
employed as a definitive treatment for AUB.  
However, despite its high cure the major 
surgical procedure has significant 
complications, requiring a long recovery time 
and resulting in high economic and social 
costs4,1. 
As the choice of operation has been moving 
towards more conservative procedures with 
minimally invasive approaches, hysteroscopic 
methods of endometrial ablation has been 
gaining popularity since its introduction in 
1980s11.  For hysteroscopic endometrial 
ablation with roller balls and /or 
resectoscopes, numerous studies attest to their 
safety and short-term success in reducing the 
menstrual flow with minimal 
complications5,12-14.  However, there are still 
concerns regarding long-term results and the 
need for further treatment.  Previous studies 
reported that free from symptoms seemed to 
diminish with time; 10-38% of patients either 
received postoperative adjuvant hormonal 
therapy or underwent repeat endometrial 
resection or hysterectomy15-17. 
It is impossible for the physician to predict in 
which patient the treatment will be successful.  
Data showed that most pitfalls occur within 
12-24 months from the initial treatment4.  
Therefore, it is important to know the factors 
that influence the success or failure of 
treatment and the recurrence of AUB in order 
to be able to plan the best therapy.  Thus the 
objective of this study was to evaluate the 
results of hysteroscopic endometrial resection 
in patients with AUB of benign etiology and 
report possible factors of success and failure 
of treatment. 
MATERIALS AND METHODS:  
A descriptive hospital - based study was 
carried out at the departments of Obstetrics 
and Gynecology and Fertility Care Unit at 
Misurata Central Hospital, Misurata Cancer 
Centre and Iben-Sina Teaching Hospital, Sirt, 
Libya, during the period from January 2009 to 
December 2013. Women aged 35-50 years 
with AUB were recruited in the study if they 
completed their families.  If they had DUB 
and medical treatment failed/ produced side 
effects.  However, presence of resectable 
submucous fibroids did not preclude 
endometrial resection.  Women with uterine 
size greater than 12 weeks pregnancy, large 
uterine fibroid, endometrial atypical 
hyperplasia or endometrial carcinoma were 
excluded from the study. 
After signing an informed consent; all women 
had a detailed medical and obstetrical history, 
physical examination, pelvic ultrasonography, 
diagnostic hysteroscopy and endometrial 
sampling.   Then uterine size, endometrial 
thickness and presence of associated uterine 
pathology were investigated.  These various 
pre-operative and intra-operative factors were 
used to assess their effect on the outcome of 
endometrial resection. 
The hysteroscopic endometrial ablation 
technique used was resection with monopolar 
electrical surgery, utilizing a 26-French 
resectoscope, with a4-mm and 30-degree 
optics.  The procedure started with 
cauterization of the uterine fundus and the 
region near to the tubal ostia with a rollerball 
loop, coagulation mode, with 90 W of power.  
Then, the resection was made with a U-loop, 
cut mode, and 90 W of power.  A region of 
approximately 1 cm of endometrium from the 
inner orifice of the uterine cervix was 
preserved.  Finally, using rollerball loop, 
hemostasis was achieved.  To produce 
distension of the uterine cavity, 1.5 % glycine 
was used, with intracavitary pressure control 
by an electronic infusion pump, maintained 
between 80 and 120 mmHg.  Any specimen 
was sent for histopathological analysis.  
No drugs were given to suppress the 
endometrium before the procedure, however 
some women received (Norethisterone 
acetate) 10 mg daily for 3 months as a 
treatment for their menstrual problems but 
without improvement.  Following surgery, 
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DISCUSSION 
Endometrial resection is the most popular 
technique of hysteroscopic endometrial 
ablation and it was introduced as a more 
conservative alternative to hysterectomy for 
selected women.  The advantages of the 
procedure were; reduced operative risks as it 
is done under direct vision, shorter operating 
times and postoperative hospital stays with 
possibly lower costs 14,16,18.  In addition, the 
excised tissue can also be examined 
histologically.  Actually, in the current study, 
endometrial resection was completed easily 
without any complications.  On the other 
hand, controversies persist regarding the risk 
of failure and long-term safety.  
The successful treatment rate in this study 
was 92.8% after 2 years follow up. Various 
success rates (52 - 98%) were previously 
reported19.  Recently, Takahashi reported a 
success rate of 80.6% after 5 years follow 
up17.  These different results of hysteroscopic 
endometrial resection could be explained by 
different methods/ patients selection criteria 
in the different studies. Perhaps endometrial 
resection success or failure is dependent on 
patients' characteristics and peri-operative 
uterine findings.    
In the current study, women with the failure 
had younger age, larger uterine size and had a 
thicker endometrium.  Shamonki et al.,   
reported a failure rate of 43% and 19% among 
women aged ≤ 40 years and > 40 years 
respectively 20.  Moreover, Gemer et al., 
reported that the risk of an adverse outcome 
declined steadily with increasing age and the 
risk of failure is less likely in women over 42 
years 21.  Age related failure may be attributed 
to the hormonal status with remarkable 
capacity of the remnant endometrium to 
regenerate with recurrence of heavy bleeding 
in younger women. 
Interestingly, in this setting 12/90 women 
who were initially recruited and 3/5 of the 
failed cases had adenomyosis on histological 
examination of the resected endometrium.  
There is a controversy whether to perform 
endometrial resection for women with 
dysmenorrhea which is likely due to 
adenomyosis or not.  Simple endometrial 
resection might not be able to resolve 
adenomyosis which -by definition -penetrate 
at least 2.5 mm into the myometrium.  Thus, 
resection must be deeper with increased risk 
of hemorrhage and uterine perforation22, 23.  
Endometrial resection followed by the 
insertion of Mirena was observed to have a 
higher rate of success in the form of 
amenorrhea in patients with adenomyosis 24.  
Therefore, if adenomyosis is suspected, 
women can be appropriately counseled so that 
they are aware of the possible failure of 
conservative management.   
The acceptable uterine size of less than 12 
weeks pregnancy and some investigators 
confined their work to an enlarged uterus 
between 8-10 weeks pregnancy25.  In fact, to 
avoid unsatisfactory outcomes, endometrial 
resection can be undertaken only when the 
uterus is of normal size or enlarged up to 8 
weeks pregnancy as greatly enlarged uterus 
lengthen the operative time and increase the 
risk of complications even before completing 
the procedure14. 
Preoperative endometrial suppression has 
been recommended as a standard practice. 
Preoperative medication with GnRH 
analogues (Danazol) has been suggested to 
provide better suppressive results and a 
success rate over 95%26.  Also, long-acting 
gestagens may confer the added advantage of 
decreasing blood flow and allowing better 
hysteroscopic visualization27.  However, 
endometrial resection could be safe and 
effective without endometrial preparation28. A 
thin endometrium allows easier destruction of 
the basal layer of endometrium, these women 
had a significantly higher success rate than 
those without treatment. In addition, 
perioperative and postoperative medical 
treatment such as long-acting gestagens and 
tranexamic acid is an option in inducing 
amenorrhea after resection29,30. 
Although previous studies showed that the 
endometrial resection may be combined with 
hysteroscopic myomectomy and myomas are 
not an absolute contraindication31,32, our study 
showed that two out of the five women with  
endometrial resection failure had  uterine 
fibroid.  In addition to the technical and visual 
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difficulties encountered by submucous fibroid 
during the procedure, regrowth of the excised 
fibroid could develop later which could lead 
to procedure failure.  This result was 
consistent with other studies which concluded 
that the presence of submucosal myoma 
increases the risk of subsequent surgery in 
patients undergoing endometrial resection25.  
This was also supported by increased 
incidence of such lesions in uteri removed by 
hysterectomy for the treatment failure.  In the 
present study, the most common lesions 
encountered were adenomyosis and small 
intramural fibroids. 
In the literature, there is sufficient evidence 
about the efficacy and safety of endometrial 
resection for the management of women with 
AUB even after repeat of the procedure33-36 
which will further reduce the incidence of 
hysterectomy.  In the present study, this 
procedure provided a chance of avoiding the 
need for hysterectomy in over 90% of the 
studied women, and it was carried out 
successfully without any complications. 
CONCLUSION: 
 Endometrial resection offers a high cure rate 
and avoids the need for hysterectomy in the 
majority of women with DUB.  However, to 
ensure successful outcome, women should be 
carefully selected to include only those who 
are > 40 years of age, without dysmenorrhea, 
with preoperative thin endometrium and have 
no uterine fibroids.  On the other hand, those 
women who are at greater risk of failure 
should be counseled for an alternative 
procedure such as hysterectomy. 
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